Lexington Releases Audited Consolidated Financial Statements

NEXT STORY
Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Antimicrobial Agents and Chemotherapy
PREV STORY
Helix BioPharma Corp. Closes Private Placement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring Inc. Prices Initial Public Offering and Concurrent Private Placement of $54.31 M

NEW YORK, March 09, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (“BeyondSpring”), a clinical stage ...

author_avatar
NASDAQ Market News

INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing

The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands ...

author_avatar
NASDAQ Market News

MDxHealth Reports Financial Year 2016 Results

NEWS RELEASE   REGULATED INFORMATION  INSIDE INFORMATION  Record revenue of $30 million, up 70% from ...

author_avatar
NASDAQ Market News